These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26908847)

  • 1. Tooth Discoloration in a Patient With Multidrug-Resistant Tuberculosis.
    Clin Infect Dis; 2016 Mar; 62(5):617; 664-5. PubMed ID: 26908847
    [No Abstract]   [Full Text] [Related]  

  • 2. [Severe linezolid-induced toxic optic neuropathy].
    Xerri O; Lemaire B; Nasser G; Rousseau-Huvey B; Labetoulle M; Rousseau A
    J Fr Ophtalmol; 2015 Mar; 38(3):e55-8. PubMed ID: 25637235
    [No Abstract]   [Full Text] [Related]  

  • 3. Does linezolid have a role in shortening treatment of tuberculosis?
    Yew WW; Chan DP; Chang KC
    Clin Microbiol Infect; 2019 Sep; 25(9):1060-1062. PubMed ID: 31238119
    [No Abstract]   [Full Text] [Related]  

  • 4. Linezolid Induced Reversible Peripheral Neuropathy.
    Vishnu VY; Modi M; Goyal MK; Lal V
    Am J Ther; 2016; 23(6):e1839-e1841. PubMed ID: 26741956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Black brown discoloration and hairy tongue - A rare linezolid side effect.
    Jain AK; Puri MM; Sarin R
    Indian J Tuberc; 2017 Jan; 64(1):44-46. PubMed ID: 28166916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linezolid in children with drug resistant tuberculosis.
    Shah I; Dey A; Shetty NS
    Infect Dis (Lond); 2018; 50(11-12):868-870. PubMed ID: 30296864
    [No Abstract]   [Full Text] [Related]  

  • 7. Linezolid in the treatment of drug-resistant tuberculosis: the challenge of its narrow therapeutic index.
    Wasserman S; Meintjes G; Maartens G
    Expert Rev Anti Infect Ther; 2016 Oct; 14(10):901-15. PubMed ID: 27532292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Severe and Long-lasting Linezolid-induced Optic Neuropathy Reversible?
    Lee S; Kang BH; Ryu WY; Um SJ; Roh MS; Son C
    Intern Med; 2018 Dec; 57(24):3611-3613. PubMed ID: 30101940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linezolid tolerability in multidrug-resistant tuberculosis: a retrospective study.
    Bolhuis MS; Tiberi S; Sotgiu G; De Lorenzo S; Kosterink JG; van der Werf TS; Migliori GB; Alffenaar JW
    Eur Respir J; 2015 Oct; 46(4):1205-7. PubMed ID: 26160870
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetics of moxifloxacin and linezolid during and after pregnancy in a patient with multidrug-resistant tuberculosis.
    Van Kampenhout E; Bolhuis MS; Alffenaar JC; Oswald LM; Kerstjens HA; de Lange WC; van der Werf TS; Akkerman OW
    Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28331037
    [No Abstract]   [Full Text] [Related]  

  • 11. Linezolid-Resistant Enterococcus faecalis Infection Following Prolonged Low-Dosage Linezolid Treatment for Multidrug-Resistant Tuberculosis.
    Baccani I; Antonelli A; Galano A; Bartalesi F; Bartoloni A; Rossolini GM
    Clin Infect Dis; 2017 Nov; 65(12):2159-2160. PubMed ID: 29020204
    [No Abstract]   [Full Text] [Related]  

  • 12. Linezolid to treat MDR-/XDR-tuberculosis: available evidence and future scenarios.
    Sotgiu G; Pontali E; Migliori GB
    Eur Respir J; 2015 Jan; 45(1):25-9. PubMed ID: 25552734
    [No Abstract]   [Full Text] [Related]  

  • 13. Haematological adverse effects associated with linezolid in patients with drug-resistant tuberculosis: an exploratory study.
    Letswee G; Kamau H; Gaida R; Truter I
    Int J Pharm Pract; 2019 Dec; 27(6):575-577. PubMed ID: 31058394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linezolid-Associated Optic Neuropathy in Drug-Resistant Tuberculosis Patients in Mumbai, India.
    Mehta S; Das M; Laxmeshwar C; Jonckheere S; Thi SS; Isaakidis P
    PLoS One; 2016; 11(9):e0162138. PubMed ID: 27611434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anemia related to linezolid-based combination regimen in drug-resistant tuberculosis.
    Putra ON; Nur Hidayatullah AY
    Int J Mycobacteriol; 2022; 11(1):130-131. PubMed ID: 35295038
    [No Abstract]   [Full Text] [Related]  

  • 16. Linezolid-containing Treatment Regimens for Tuberculosis in Children.
    Prieto LM; Santiago B; Del Rosal T; Carazo B; Jiménez AB; Pérez-Gorricho B; Rubio F; Tagarro A; Blázquez-Gamero D; Moreno-Pérez D; Mellado MJ; Baquero-Artigao F;
    Pediatr Infect Dis J; 2019 Mar; 38(3):263-267. PubMed ID: 29750764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible recurrent profound thrombocytopenia due to linezolid in a patient with multi-drug resistant tuberculosis: A case report.
    Wang MG; Wang D; He JQ
    Medicine (Baltimore); 2018 Aug; 97(34):e11997. PubMed ID: 30142839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of Linezolid Hair Concentrations with Plasma Exposure in Patients with Drug-Resistant Tuberculosis.
    Wasserman S; Huo S; Ky K; Malig YN; Esmail A; Dheda K; Bacchetti P; Gerona R; Maartens G; Gandhi M; Metcalfe J
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31932382
    [No Abstract]   [Full Text] [Related]  

  • 19. Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06.
    Anger HA; Dworkin F; Sharma S; Munsiff SS; Nilsen DM; Ahuja SD
    J Antimicrob Chemother; 2010 Apr; 65(4):775-83. PubMed ID: 20150181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linezolid in the treatment of multidrug-resistant tuberculosis.
    Schecter GF; Scott C; True L; Raftery A; Flood J; Mase S
    Clin Infect Dis; 2010 Jan; 50(1):49-55. PubMed ID: 19947856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.